SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
14-Aug-23 4:09 PM View: | Seelenberger Alexander A. See Remarks | Vincerx Pharma, Inc. (LSAC) | 11-Aug-23 | Private Purchase | 10,500 | $0.95 | $9,967.65 | 53% 19.78K to 30.28K | |
10-Aug-23 6:28 PM View: | Hamdy Ahmed Md See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 10-Aug-23 | Purchase | 5,400 | $0.96 | $5,167.26 | < 1% 1.8M to 1.8M | |
10-Aug-23 6:28 PM View: | Thomas Tom C See Remarks | Vincerx Pharma, Inc. (LSAC) | 10-Aug-23 | Private Purchase | 5,000 | $0.95 | $4,750.00 | 2% 224.94K to 229.94K | |
10-Aug-23 6:27 PM View: | Izumi Raquel E. See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 10-Aug-23 | Purchase | 3,440 | $0.93 | $3,199.20 | < 1% 1.78M to 1.79M | |
10-Aug-23 6:28 PM View: | Hamdy Ahmed Md See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 09-Aug-23 | Private Purchase | 16,900 | $0.95 | $15,994.20 | < 1% 1.78M to 1.8M | |
10-Aug-23 6:27 PM View: | Izumi Raquel E. See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 09-Aug-23 | Private Purchase | 13,036 | $0.90 | $11,735.00 | < 1% 1.77M to 1.78M | |
14-Dec-22 9:22 PM View: | Hamdy Ahmed Md Chief Executive Officer Director | Vincerx Pharma, Inc. (LSAC) | 14-Dec-22 | Private Purchase | 35,280 | $0.87 | $30,538.40 | 2% 1.66M to 1.69M | |
14-Dec-22 9:22 PM View: | Izumi Raquel E. See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 14-Dec-22 | Private Purchase | 28,738 | $0.88 | $25,427.40 | 2% 1.66M to 1.69M | |
14-Dec-22 9:22 PM View: | Thomas Tom C See Remarks | Vincerx Pharma, Inc. (LSAC) | 14-Dec-22 | Private Purchase | 7,000 | $0.83 | $5,810.00 | 3% 212.94K to 219.94K | |
26-Aug-22 4:06 PM View: | Lowe Christopher P. Director | Vincerx Pharma, Inc. (LSAC) | 25-Aug-22 | Purchase | 11,600 | $1.65 | $19,138.80 | 41% 28.4K to 40.0K | |
26-Aug-22 4:06 PM View: | Lowe Christopher P. Director | Vincerx Pharma, Inc. (LSAC) | 24-Aug-22 | Private Purchase | 18,400 | $1.65 | $30,299.30 | 184% 10.0K to 28.4K | |
29-Jun-22 4:05 PM View: | Izumi Raquel E. See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 27-Jun-22 | Private Purchase | 40,000 | $1.41 | $56,312.00 | 2% 1.62M to 1.66M | |
27-Jun-22 7:20 PM View: | Hamdy Ahmed Md Chief Executive Officer Director | Vincerx Pharma, Inc. (LSAC) | 23-Jun-22 | Private Purchase | 24,200 | $1.41 | $34,136.50 | 1% 1.63M to 1.66M | |
13-Jun-22 8:01 PM View: | Bushnell Laura I. Director | Vincerx Pharma, Inc. (LSAC) | 09-Jun-22 | Private Purchase | 15,000 | $1.91 | $28,624.50 | 357% 4.2K to 19.2K | |
27-Dec-21 4:42 PM View: | Hwang Sooin Chief Business Officer | Vincerx Pharma, Inc. (LSAC) | 23-Dec-21 | Private Purchase | 3,000 | $10.00 | $30,000.00 | < 1% 387.49K to 390.49K | |
27-Dec-21 4:39 PM View: | Bushnell Laura I. Director | Vincerx Pharma, Inc. (LSAC) | 22-Dec-21 | Private Purchase | 2,402 | $10.48 | $25,173.00 | 133% 1.8K to 4.2K | |
27-Dec-21 4:28 PM View: | Hamdy Ahmed Md Chief Executive Officer Director | Vincerx Pharma, Inc. (LSAC) | 22-Dec-21 | Private Purchase | 6,450 | $10.02 | $64,649.60 | < 1% 1.63M to 1.63M | |
27-Dec-21 4:48 PM View: | Thomas Tom C See Remarks | Vincerx Pharma, Inc. (LSAC) | 22-Dec-21 | Private Purchase | 1,000 | $10.23 | $10,230.00 | < 1% 208.94K to 209.94K | |
27-Dec-21 4:34 PM View: | Seelenberger Alexander A. Chief Financial Officer | Vincerx Pharma, Inc. (LSAC) | 22-Dec-21 | Private Purchase | 2,417 | $10.34 | $24,987.90 | 24% 10.08K to 12.49K | |
06-Aug-21 4:45 PM View: | Izumi Raquel E. See Remarks Director | Vincerx Pharma, Inc. (LSAC) | 04-Aug-21 | Private Purchase | 1,000 | $11.96 | $11,960.00 | < 1% 1.62M to 1.62M | |
30-Jun-21 6:56 PM View: | Hwang Sooin Chief Business Officer | Vincerx Pharma, Inc. (LSAC) | 30-Jun-21 | Private Purchase | 500 | $12.66 | $6,330.00 | < 1% 385.07K to 385.57K | |
30-Jun-21 6:59 PM View: | Lowe Christopher P. Director | Vincerx Pharma, Inc. (LSAC) | 30-Jun-21 | Private Purchase | 3,600 | $12.66 | $45,576.00 | 56% 6.4K to 10.0K | |
30-Jun-21 7:02 PM View: | Bushnell Laura I. Director | Vincerx Pharma, Inc. (LSAC) | 30-Jun-21 | Private Purchase | 1,800 | $12.94 | $23,297.40 | 100% 0 to 1.8K | |
30-Jun-21 6:57 PM View: | Thomas Tom C See Remarks | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 2,000 | $12.58 | $25,160.00 | < 1% 205.52K to 207.52K | |
30-Jun-21 6:59 PM View: | Seelenberger Alexander A. Chief Financial Officer | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 7,950 | $12.61 | $100,260.00 | 100% 0 to 7.95K | |
30-Jun-21 6:59 PM View: | Lowe Christopher P. Director | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 6,400 | $12.59 | $80,576.00 | 100% 0 to 6.4K | |
01-Jul-21 6:05 AM View: | McDonald Andrew I Director | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 20,000 | $12.38 | $247,600.00 | 2% 808.47K to 828.47K | |
30-Jun-21 7:02 PM View: | Hamdy Ahmed Md Chief Executive Officer Director | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 7,830 | $12.77 | $99,989.10 | < 1% 1.62M to 1.63M | |
01-Jul-21 6:52 PM View: | Lee John H. Director | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 799 | $12.72 | $10,159.30 | 100% 0 to 0.8K | |
02-Feb-21 6:08 AM View: | McDonald Andrew I Director | Vincerx Pharma, Inc. (LSAC) | 28-Jan-21 | Acquisition (other) | 808,471 | -- | -- | 50% 1.62M to 2.43M | |
02-Feb-21 6:08 AM View: | McDonald Andrew I Director | Vincerx Pharma, Inc. (LSAC) | 28-Jan-21 | Disposition (other) | 1,616,940 | -- | -- | (67%) 2.43M to 808.47K | |
28-Dec-20 9:14 PM View: | Byrd John C. 10% Owner | Vincerx Pharma, Inc. (LSAC) | 23-Dec-20 | Grant | 1,618,200 | -- | -- | 100% 0 to 1.62M | |
28-Dec-20 9:41 PM View: | Hamdy Ahmed Md President and CEO Director 10% Owner | Vincerx Pharma, Inc. (LSAC) | 23-Dec-20 | Grant | 1,618,200 | -- | -- | 100% 0 to 1.62M | |
28-Dec-20 9:24 PM View: | Druker Brian Director | Vincerx Pharma, Inc. (LSAC) | 23-Dec-20 | Grant | 54,806 | -- | -- | 100% 0 to 54.81K | |
28-Dec-20 9:37 PM View: | Izumi Raquel E. Chief Operations Officer Director 10% Owner | Vincerx Pharma, Inc. (LSAC) | 23-Dec-20 | Grant | 1,618,200 | -- | -- | 100% 0 to 1.62M |